Search

Your search keyword '"Carpten J."' showing total 222 results

Search Constraints

Start Over You searched for: Author "Carpten J." Remove constraint Author: "Carpten J."
222 results on '"Carpten J."'

Search Results

1. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

2. 18P Systematic evaluation of published predictive gene expression signatures in pan-cancer patient cohorts treated with immune checkpoint inhibitors in a real-world setting

3. 322P Genomic landscape of early-onset sporadic colorectal cancer

5. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

6. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer[Formula presented].

7. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

8. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer

9. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

10. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

11. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

15. Molecular classification of cutaneous malignant melanoma by gene expression profiling

22. Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African ancestry anthropometry genetics consortium

23. Abstract P6-07-01: Withdrawn

24. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

25. Abstract P1-07-09: A multi-OMIC analysis to explore the impact of “actionable” genomic alterations on protein pathway activation: Clinical implication for precision medicine in metastatic breast cancer

26. Two susceptibility loci identified for prostate cancer aggressiveness

28. Abstract P2-05-21: The AKT-mTOR pathway as a potential organ-specific drug target signature of hepatic metastases from breast cancer

29. Interim Analysis of the MMRF CoMMpass Study: Comprehensive Characterization of Multiple Myeloma Patients at Diagnosis Reveals Distinct Molecular Subtypes and Clinical Outcomes

30. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

31. Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias

34. Moving AHEAD with an international human epigenome project.

36. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP

37. LAB-OMICS AND PROGNOSTIC MARKERS

38. LINKAGE MAPPING OF THE SPINAL MUSCULAR-ATROPHY GENE

39. Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

40. Two Genome-wide Association Studies of Aggressive Prostate Cancer Implicate Putative Prostate Tumor Suppressor Gene DAB2IP

41. Admixture and Population Stratification in African Caribbean Populations

43. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

45. Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome

48. Methods for precise sizing, automated binning of alleles, and reduction of error rates in large-scale genotyping using fluorescently labeled dinucleotide markers. FUSION (Finland-U.S. Investigation of NIDDM Genetics) Study Group.

50. A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.

Catalog

Books, media, physical & digital resources